Contrast enhanced ultrasound: Roles in immediate post-procedural and 24-h evaluation of the effectiveness of thermal ablation of liver tumors

Journal of Ultrasound

Volumn 15, Issue 4, 2012, Pages 207-214

  Meloni, M F ^a,b   Andreano, A ^a   Zimbaro, F ^c   Lava, M ^d   Lazzaroni, S ^e   Sironi, S ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e MOA Locatelli Hospital   (Italy)

Author keywords

Ablation techniques; Contrast enhanced ultrasound; Interventional; Sensitivity and specificity; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR ABLATION; TUMOR VOLUME; ULTRASOUND;

EID: 84870249641     PISSN: 19713495     EISSN: 18767931     Source Type: Journal    
DOI: 10.1016/j.jus.2012.09.001     Document Type: Article

References (22)

1. Llovet J.M., Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008, 48(Suppl. 1):S20-S37.
2. Mulier S., Ni Y., Jamart J., Ruers T., Marchal G., Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005, 242:158-171.
3. Meloni M.F., Andreano A., Laeseke P.F., Livraghi T., Sironi S., Lee F.T. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation - intermediate and long-term survival rates. Radiology 2009, 253:861-869.
4. Gillams A.R., Lees W.R. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol 2008, 19:712-717.
5. Goldberg S.N. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001 Jun, 13(2):129-147. Review.
6. Shiina S. Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009, 44(Suppl. 19):122-131.
7. Nikfarjam M., Christophi C. Interstitial laser thermotherapy for liver tumours. Br J Surg 2003, 90:1033-1047.
8. Ong S.L., Gravante G., Metcalfe M.S., Strickland A.D., Dennison A.R., Lloyd D.M. Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol 2009, 21:599-605.
9. Kim S.K., Lim H.K., Kim Y.H., Lee W.J., Lee S.J., Kim S.H., et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 2003, 23:107-121.
10. Park M., Rhim H., Kim Y., Choi D., Lim H.K., Lee W.J. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 2008, 28:379-390.
11. Schraml C., Clasen S., Schwenzer N.F., Koenigsrainer I., Herberts T., Claussen C.D., et al. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging 2008, 33:643-651.
12. Breen M.S., Lazebnik R.S., Fitzmaurice M., Nour S.G., Lewin J.S., Wilson D.L. Radiofrequency thermal ablation: correlation of hyperacute MR lesion images with tissue response. J Magn Reson Imaging 2004, 20:475-486.
13. Cha C.H., Lee F.T., Gurney J.M., Markhardt B.K., Warner T.F., Kelcz F., et al. CT versus sonography for monitoring radiofrequency ablation in a porcine liver. AJR Am J Roentgenol 2000, 175:705-711.
14. Raman S.S., Lu D.S., Vodopich D.J., Sayre J., Lassman C. Creation of radiofrequency lesions in a porcine model: correlation with sonography, MDCT, and histopathology. AJR Am J Roentgenol 2000, 175:1253-1258.
15. Leyendecker J.R., Dodd G.D., Halff G.A., McCoy V.A., Napier D.H., Hubbard L.G., et al. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 2002, 178:1147-1151.
16. Dill-Macky M.J., Asch M., Burns P., Wilson S. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 2006, 186:S287-S295.
17. Numata K., Fukuda H., Ohto M., Itou R., Nozaki A., Kondou M., et al. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Eur J Radiol 2010, 75:e67-e75.
18. Yanagisawa K., Moriyasu F., Miyahara T., Yuki M., Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007, 33:318-325.
19. Kim C.K., Choi D., Lim H.K., Kim S.H., Lee W.J., Kim M.J., et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005, 56:66-73.
20. Choi D., Lim H.K., Lee W.J., Kim S.H., Kim Y.H., Kim S.H., et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003, 22:1163-1172.
21. Meloni M.F., Goldberg S.N., Livraghi T., Calliada F., Ricci P., Rossi M., et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001, 177:375-380.
22. Morimoto M., Nozawa A., Numata K., Shirato K., Sugimori K., Kokawa A., et al. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med 2005, 24:273-283.